Here's the live share price of Vimta Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Vimta Labs | 4.57 | -5.48 | -21.64 | 3.69 | -22.83 | 36.42 | 23.10 |
| Suven Life Sciences | 7.88 | -1.54 | -15.28 | 29.13 | 50.65 | 48.89 | 26.78 |
| Sun Pharma Advanced Research Company | 21.31 | 15.41 | 2.55 | 26.71 | 62.42 | -5.59 | -4.61 |
| Choksi Laboratories | -1.41 | -1.44 | 64.65 | 95.10 | 46.04 | 42.53 | 59.36 |
| Vanta Bioscience | -1.87 | 7.69 | 6.39 | 22.17 | -16.13 | -24.15 | -28.66 |
Source: Dion Global
Over the last one year, Vimta Labs has declined 22.83% compared to peers like Suven Life Sciences (50.65%), Sun Pharma Advanced Research Company (62.42%), Choksi Laboratories (46.04%). From a 5 year perspective, Vimta Labs has outperformed peers relative to Suven Life Sciences (26.78%) and Sun Pharma Advanced Research Company (-4.61%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 502.77 | 502.1 |
| 10 | 500.42 | 501.93 |
| 20 | 503.74 | 512.28 |
| 50 | 565.28 | 544.03 |
| 100 | 580.96 | 554.8 |
| 200 | 522.58 | 551.13 |
Source: Dion Global
In the latest quarter, Vimta Labs saw a drop in promoter holding to 35.63%, while DII stake increased to 0.48%, FII holding rose to 5.07%, and public shareholding moved down to 58.79% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 04, 2026, 08:48 PM IST IST | Vimta Labs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Oct 31, 2026, 01:20 AM IST IST | Vimta Labs - Announcement under Regulation 30 (LODR)-Acquisition |
| Oct 30, 2026, 11:27 PM IST IST | Vimta Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 30, 2026, 07:29 PM IST IST | Vimta Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 30, 2026, 06:58 PM IST IST | Vimta Labs - Announcement under Regulation 30 (LODR)-Investor Presentation |
Source: Dion Global
Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently Company is involved in the business activities of Technical testing and analysis. Company's Total Operating Revenue is Rs. 407.29 Cr. and Equity Capital is Rs. 8.93 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vimta Labs is ₹510.80 as on Nov 11, 2026.
The Vimta Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vimta Labs is ₹2,276.17 Cr as on Nov 11, 2026.
Today’s highest and lowest price of Vimta Labs are ₹511.10 and ₹505.50.
The 52-week high/low is the highest and lowest price at which Vimta Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Vimta Labs is ₹675.00 and 52-week low of Vimta Labs is ₹377.30 as on Nov 11, 2026.
The Vimta Labs has shown returns of 1.12% over the past day, -5.36% for the past month, -21.54% over 3 months, -22.73% over 1 year, 36.48% across 3 years, and 23.13% over 5 years.
P/E ratio of and PB ratio of Vimta Labs are 37.09 and 6.64 on Nov 11, 2026. While the company gives a dividend yield of 0.39 per annum.
Source: Dion Global